Skip to main content
. 2016 Nov 2;104(6):1671–1682. doi: 10.3945/ajcn.116.137075

TABLE 1.

Baseline demographic and other selected characteristics of study participants1

Variables GTE (n = 463) Placebo (n = 473) P
Age at baseline, y 60.02 ± 4.89 59.65 ± 5.04 0.26
Weight, kg 67.34 ± 10.66 67.40 ± 10.33 0.93
BMI, kg/m2 25.16 ± 3.72 25.01 ± 3.73 0.53
Waist-to-hip ratio2 0.84 ± 0.07 0.83 ± 0.07 0.22
Race,3 n (%)
 White 453 (98.05) 457 (97.03) 0.31
 Nonwhite 9 (1.95) 14 (2.97)
Ethnicity,4 n (%)
 Hispanic 5 (1.09) 4 (0.86) 0.72
 Non-Hispanic 453 (98.91) 463 (99.14)
Smoking status,5 n (%)
 Never 316 (68.55) 324 (68.64) 0.97
 Former 145 (31.45) 148 (31.36)
Educational level (degree),6 n (%)
 High school or less 27 (5.86) 31 (6.61) 0.08
 Some college 313 (67.90) 286 (60.98)
 Postgraduate or professional 121 (26.25) 152 (32.41)
Regular use of vitamin and/or mineral supplements,7,8 n (%)
 No 42 (9.09) 66 (13.95) 0.02
 Yes 420 (90.91) 407 (86.05)
Regular use of aspirin,8,9 n (%)
 No 339 (73.22) 341 (72.25) 0.74
 Yes 124 (26.78) 131 (27.75)
Regular use of statins,8,10 n (%)
 No 360 (78.43) 378 (80.60) 0.41
 Yes 99 (21.57) 91 (19.40)
Consumption of soy,8,11 n (%)
 No 327 (71.40) 307 (66.16) 0.09
 Yes 131 (28.60) 157 (33.84)
 Times/wk12 2.39 ± 2.68 1.98 ± 2.48 0.21
Regular consumption of black and/or green tea,8 n (%)
 No 187 (40.39) 179 (37.84) 0.21
 Yes 275 (59.40) 289 (61.10)
 Unknown 1 (0.22) 5 (1.06)
Years since menopause13 11.07 ± 7.63 10.32 ± 7.24 0.13
Self-reported physical activity,9 MET-h/wk 45.71 ± 53.97 51.07 ± 106.95 0.33
1

Values are means ± SDs for continuous variables or frequencies (percentages) for categorical variables. P values were derived from Student’s t test for continuous variables and Pearson’s chi-square test for categorical variables. GTE, green tea extract; MET-h, metabolic equivalent hours.

2–6

2–6Participant numbers for the GTE and placebo groups, respectively, are as follows: 2n = 461 and 473, 3462 and 471, 4458 and 467, 5461 and 472, and 6461 and 469.

7

n = 462 for the GTE group.

8

Self-reported on the baseline health history questionnaire.

9

n = 472 for the placebo group.

10–13

10–13Participant numbers for the GTE and placebo groups, respectively, are as follows: 10n = 459 and 469, 11458 and 464, 12119 and 143, and 13440 and 453.